Announcements Trials
Browse Landscape

Phase

Phase NA 29Phase 1 4Phase 2 3

Status

Completed 3Active not recruiting 3Terminated 2

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Rectal Neoplasms 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Diet Therapy × Clear all
NCT03654638 2025-04-04

Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
25 enrolled
Genitourinary

Prostate Adenocarcinoma

NCT04205955 2024-05-01

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

SWOG Cancer Research Network

Phase 2 Completed
95 enrolled 30 charts
Gastrointestinal

Rectal Neoplasms

NCT00049309 2017-02-23

Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer

Duke University

Phase 2 Completed
161 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡